{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:01:46Z","timestamp":1785528106141,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Provincial Key Discipline and Laboratory Construction Funds of Urology","award":["2023YXZDXK02"],"award-info":[{"award-number":["2023YXZDXK02"]}]},{"name":"the National Clinical Key Discipline Construction Funds","award":["CZXM-ZK-47"],"award-info":[{"award-number":["CZXM-ZK-47"]}]},{"name":"Research Project of the National Health Commission\u2019s Research Center for Medical and Health Science and Technology Development","award":["WKZX2025QZ0159"],"award-info":[{"award-number":["WKZX2025QZ0159"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-026-02170-w","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:23:42Z","timestamp":1780028622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between hepatitis C virus and overactive bladder: a cross-sectional study based on the 2013\u20132018 NHANES"],"prefix":"10.1186","volume":"26","author":[{"given":"Yiming","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonglei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dakun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weipu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"1","key":"2170_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00192-009-0976-9","volume":"21","author":"BT Haylen","year":"2010","unstructured":"Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21(1):5\u201326.","journal-title":"Int Urogynecol J"},{"issue":"6","key":"2170_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","volume":"20","author":"WF Stewart","year":"2003","unstructured":"Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327\u201336.","journal-title":"World J Urol"},{"issue":"8","key":"2170_CR3","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00192-024-06029-2","volume":"36","author":"L Zhang","year":"2025","unstructured":"Zhang L, Cai N, Mo L, Tian X, Liu H, Yu B. Global Prevalence of Overactive Bladder: A Systematic Review and Meta-analysis. Int Urogynecol J. 2025;36(8):1547\u201366.","journal-title":"Int Urogynecol J"},{"issue":"5","key":"2170_CR4","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/nau.23513","volume":"37","author":"E Durden","year":"2018","unstructured":"Durden E, Walker D, Gray S, Fowler R, Juneau P, Gooch K. The economic burden of overactive bladder (OAB) and its effects on the costs associated with other chronic, age-related comorbidities in the United States. Neurourol Urodyn. 2018;37(5):1641\u20139.","journal-title":"Neurourol Urodyn"},{"issue":"4 Suppl","key":"2170_CR5","first-page":"S98","volume":"15","author":"CC Sexton","year":"2009","unstructured":"Sexton CC, Coyne KS, Vats V, Kopp ZS, Irwin DE, Wagner TH. Impact of overactive bladder on work productivity in the United States: results from EpiLUTS. Am J Manag Care. 2009;15(4 Suppl):S98\u2013107.","journal-title":"Am J Manag Care"},{"issue":"5","key":"2170_CR6","doi-asserted-by":"publisher","first-page":"e70022","DOI":"10.1002\/bco2.70022","volume":"6","author":"W Mao","year":"2025","unstructured":"Mao W, Barge S, Luo Z, Yu W. Association of overactive bladder with all-cause and cardiovascular mortality in women: A propensity-matched NHANES study. BJUI Compass. 2025;6(5):e70022.","journal-title":"BJUI Compass"},{"key":"2170_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.urology.2018.12.021","volume":"126","author":"K McKellar","year":"2019","unstructured":"McKellar K, Bellin E, Schoenbaum E, Abraham N, Prevalence. Risk Factors, and Treatment for Overactive Bladder in a Racially Diverse Population. Urology. 2019;126:70\u20135.","journal-title":"Urology"},{"issue":"2","key":"2170_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/liv.12617","volume":"35","author":"EM El-Ghitany","year":"2015","unstructured":"El-Ghitany EM, Abdel Wahab MM, Abd El-Wahab EW, Hassouna S, Farghaly AG. A comprehensive hepatitis C virus risk factors meta-analysis (1989\u20132013): do they differ in Egypt? Liver Int. 2015;35(2):489\u2013501.","journal-title":"Liver Int"},{"issue":"3","key":"2170_CR9","doi-asserted-by":"publisher","first-page":"100041","DOI":"10.1016\/j.engmed.2024.100041","volume":"1","author":"C Liu","year":"2024","unstructured":"Liu C, Wang Y, Zhou X, Dong L. Advances in liver engineering with cell, scaffold, and vascularization. EngMedicine. 2024;1(3):100041.","journal-title":"EngMedicine"},{"issue":"11","key":"2170_CR10","doi-asserted-by":"publisher","first-page":"e70092","DOI":"10.1111\/jvh.70092","volume":"32","author":"C Oltmanns","year":"2025","unstructured":"Oltmanns C, Witte M, Wranke A, Deterding K, Wedemeyer H, Falk CS, et al. HBV Dominance Is Associated With a Distinct Inflammatory Milieu in HBV\/HCV Coinfection. J Viral Hepatitis. 2025;32(11):e70092.","journal-title":"J Viral Hepatitis"},{"key":"2170_CR11","doi-asserted-by":"publisher","first-page":"1401323","DOI":"10.3389\/fcimb.2024.1401323","volume":"14","author":"F Yang","year":"2024","unstructured":"Yang F, Luo J. The association between hepatitis C virus infection status and blood pressure in adults in the United States: NHANES 1999\u20132012. Front Cell Infect Microbiol. 2024;14:1401323.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"2170_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.diabres.2006.07.008","volume":"75","author":"M Shaheen","year":"2007","unstructured":"Shaheen M, Echeverry D, Oblad MG, Montoya MI, Teklehaimanot S, Akhtar AJ, Hepatitis C. metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III]. Diabetes Res Clin Pract. 2007;75(3):320\u20136.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"2170_CR13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/cac2.12143","volume":"41","author":"N Li","year":"2021","unstructured":"Li N, Wu P, Shen Y, Yang C, Zhang L, Chen Y, et al. Predictions of mortality related to four major cancers in China, 2020 to 2030. Cancer Commun. 2021;41(5):404\u201313.","journal-title":"Cancer Commun"},{"key":"2170_CR14","doi-asserted-by":"crossref","unstructured":"Chuang PH, Chang YH, Hsiao PJ, Chou EC. Diagnostic Potential of Low Serum Platelet, Albumin and Prolong PT-INR for Overactive Bladder and Nocturia in Chronic Hepatitis-Related Liver Cirrhosis. J Clin Med. 2021;10(13).","DOI":"10.3390\/jcm10132838"},{"issue":"Suppl 1","key":"2170_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/liv.13022","volume":"36","author":"M Corouge","year":"2016","unstructured":"Corouge M, Vallet-Pichard A, Pol S. HCV and the kidney. Liver Int. 2016;36(Suppl 1):28\u201333.","journal-title":"Liver Int"},{"issue":"3","key":"2170_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.nefroe.2020.06.005","volume":"40","author":"F Fabrizi","year":"2020","unstructured":"Fabrizi F, Cerutti R, Dixit V, Messa P. The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis. Nefrologia (Engl Ed). 2020;40(3):299\u2013310.","journal-title":"Nefrologia (Engl Ed)"},{"issue":"1","key":"2170_CR17","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1186\/s12889-024-20331-0","volume":"24","author":"R Nawaz","year":"2024","unstructured":"Nawaz R, Ahmad M, Raza MS, Rashad M, Nawaz A, Tabassum K, et al. Coincidence of HCV and chronic kidney disease-a systematic review and meta-analysis. BMC Public Health. 2024;24(1):2842.","journal-title":"BMC Public Health"},{"issue":"24","key":"2170_CR18","doi-asserted-by":"publisher","first-page":"7544","DOI":"10.3748\/wjg.v20.i24.7544","volume":"20","author":"A Ozkok","year":"2014","unstructured":"Ozkok A, Yildiz A. Hepatitis C virus associated glomerulopathies. World J Gastroenterol. 2014;20(24):7544\u201354.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2170_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.juro.2007.03.133","volume":"178","author":"JG Blaivas","year":"2007","unstructured":"Blaivas JG, Panagopoulos G, Weiss JP, Somaroo C. Validation of the overactive bladder symptom score. J Urol. 2007;178(2):543\u20137. discussion 7.","journal-title":"J Urol"},{"key":"2170_CR20","doi-asserted-by":"crossref","unstructured":"Han JY, Kwon JH, Kim SH, Lee H. Hepatitis Risk in Diabetes Compared to Non-Diabetes and Relevant Factors: A Cross-Sectional Study with National Health and Nutrition Examination Survey (NHANES), 2013\u20132018. Int J Environ Res Public Health. 2023;20(6).","DOI":"10.3390\/ijerph20064962"},{"issue":"6","key":"2170_CR21","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","volume":"75","author":"B Peyronnet","year":"2019","unstructured":"Peyronnet B, Mironska E, Chapple C, Cardozo L, Oelke M, Dmochowski R, et al. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol. 2019;75(6):988\u20131000.","journal-title":"Eur Urol"},{"issue":"1","key":"2170_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/pcan.2015.43","volume":"19","author":"Q He","year":"2016","unstructured":"He Q, Wang Z, Liu G, Daneshgari F, MacLennan GT, Gupta S. Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links. Prostate Cancer Prostatic Dis. 2016;19(1):7\u201313.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2170_CR23","doi-asserted-by":"crossref","unstructured":"Hsu LN, Hu JC, Chen PY, Lee WC, Chuang YC. Metabolic Syndrome and Overactive Bladder Syndrome May Share Common Pathophysiologies. Biomedicines. 2022;10(8).","DOI":"10.3390\/biomedicines10081957"},{"issue":"8","key":"2170_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/hiv.12357","volume":"17","author":"KV Shmagel","year":"2016","unstructured":"Shmagel KV, Saidakova EV, Shmagel NG, Korolevskaya LB, Chereshnev VA, Robinson J, et al. Systemic inflammation and liver damage in HIV\/hepatitis C virus coinfection. HIV Med. 2016;17(8):581\u20139.","journal-title":"HIV Med"},{"issue":"5","key":"2170_CR25","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1002\/hep.32008","volume":"74","author":"LN Nguyen","year":"2021","unstructured":"Nguyen LN, Nguyen LNT, Zhao J, Schank M, Dang X, Cao D, et al. Immune Activation Induces Telomeric DNA Damage and Promotes Short-Lived Effector T Cell Differentiation in Chronic HCV Infection. Hepatology. 2021;74(5):2380\u201394.","journal-title":"Hepatology"},{"key":"2170_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijid.2016.02.025","volume":"45","author":"X Meng","year":"2016","unstructured":"Meng X, Wei G, Chang Q, Peng R, Shi G, Zheng P, et al. The platelet-to-lymphocyte ratio, superior to the neutrophil-to-lymphocyte ratio, correlates with hepatitis C virus infection. Int J Infect Dis. 2016;45:72\u20137.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"2170_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.dld.2018.09.016","volume":"51","author":"A Casadei Gardini","year":"2019","unstructured":"Casadei Gardini A, Foschi FG, Conti F, Petracci E, Vukotic R, Marisi G, et al. Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals. Dig Liver Dis. 2019;51(5):681\u20138.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"2170_CR28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10238-019-00561-y","volume":"19","author":"A Wr\u00f3blewska","year":"2019","unstructured":"Wr\u00f3blewska A, Lorenc B, Cheba M, Bielawski KP, Sikorska K. Neutrocyte-to-lymphocyte ratio predicts the presence of a replicative hepatitis C virus strand after therapy with direct-acting antivirals. Clin Exp Med. 2019;19(3):401\u20136.","journal-title":"Clin Exp Med"},{"issue":"1","key":"2170_CR29","doi-asserted-by":"publisher","first-page":"12579","DOI":"10.1038\/s41598-024-63448-3","volume":"14","author":"B Wei","year":"2024","unstructured":"Wei B, Zhao Y, Lin P, Qiu W, Wang S, Gu C, et al. The association between overactive bladder and systemic immunity-inflammation index: a cross-sectional study of NHANES 2005 to 2018. Sci Rep. 2024;14(1):12579.","journal-title":"Sci Rep"},{"issue":"10","key":"2170_CR30","doi-asserted-by":"publisher","first-page":"e048309","DOI":"10.1136\/bmjopen-2020-048309","volume":"11","author":"S Kim","year":"2021","unstructured":"Kim S, Park JH, Oh YH, Kim HJ, Kong MH, Moon J. Correlation between neutrophil to lymphocyte ratio and overactive bladder in South Korean women: a community-based, cross-sectional study. BMJ Open. 2021;11(10):e048309.","journal-title":"BMJ Open"},{"issue":"1","key":"2170_CR31","doi-asserted-by":"publisher","first-page":"F28","DOI":"10.1152\/ajprenal.00580.2015","volume":"311","author":"E Ma","year":"2016","unstructured":"Ma E, Vetter J, Bliss L, Lai HH, Mysorekar IU, Jain S. A multiplexed analysis approach identifies new association of inflammatory proteins in patients with overactive bladder. Am J Physiol Ren Physiol. 2016;311(1):F28\u201334.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"2 Suppl 1","key":"2170_CR32","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1002\/hep.21060","volume":"43","author":"V Racanelli","year":"2006","unstructured":"Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology. 2006;43(2 Suppl 1):S54\u201362.","journal-title":"Hepatology"},{"issue":"6","key":"2170_CR33","doi-asserted-by":"publisher","first-page":"20210157","DOI":"10.1002\/EXP.20210157","volume":"2","author":"H Dai","year":"2022","unstructured":"Dai H, Fan Q, Wang C. Recent applications of immunomodulatory biomaterials for disease immunotherapy. Exploration. 2022;2(6):20210157.","journal-title":"Exploration"},{"issue":"3","key":"2170_CR34","doi-asserted-by":"publisher","first-page":"e0247861","DOI":"10.1371\/journal.pone.0247861","volume":"16","author":"Z Chen","year":"2021","unstructured":"Chen Z, Ognenovska S, Sluyter R, Moore KH, Mansfield KJ. Urinary cytokines in women with refractory detrusor overactivity: A longitudinal study of rotating antibiotic versus placebo treatment. PLoS ONE. 2021;16(3):e0247861.","journal-title":"PLoS ONE"},{"issue":"1","key":"2170_CR35","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12883-020-01952-5","volume":"20","author":"J Rahmig","year":"2020","unstructured":"Rahmig J, Grey A, Berning M, Schaefer J, Lesser M, Reichmann H, et al. Disseminated inflammation of the central nervous system associated with acute hepatitis E: a case report. BMC Neurol. 2020;20(1):391.","journal-title":"BMC Neurol"},{"issue":"6","key":"2170_CR36","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1212\/01.wnl.0000252931.77486.1a","volume":"68","author":"KM Aktipi","year":"2007","unstructured":"Aktipi KM, Ravaglia S, Ceroni M, Nemni R, Debiaggi M, Bastianello S, et al. Severe recurrent myelitis in patients with hepatitis C virus infection. Neurology. 2007;68(6):468\u20139.","journal-title":"Neurology"},{"issue":"9","key":"2170_CR37","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1097\/QAD.0000000000001474","volume":"31","author":"E Todesco","year":"2017","unstructured":"Todesco E, Demeret S, Calin R, Roque-Afonso AM, Thibault V, Mallet V, et al. Chronic hepatitis E in HIV\/HBV coinfected patient: lack of power of sofosbuvir-ribavirin. Aids. 2017;31(9):1346\u20138.","journal-title":"Aids"},{"issue":"2","key":"2170_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/ijcp.12518","volume":"69","author":"F Bunn","year":"2015","unstructured":"Bunn F, Kirby M, Pinkney E, Cardozo L, Chapple C, Chester K, et al. Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies. Int J Clin Pract. 2015;69(2):199\u2013217.","journal-title":"Int J Clin Pract"},{"issue":"Suppl 2","key":"2170_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1478-3231.2008.01952.x","volume":"29","author":"L Serfaty","year":"2009","unstructured":"Serfaty L, Capeau J, Hepatitis C. insulin resistance and diabetes: clinical and pathogenic data. Liver Int. 2009;29(Suppl 2):13\u201325.","journal-title":"Liver Int"},{"issue":"4","key":"2170_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5213\/inj.2012.16.4.181","volume":"16","author":"H Uzun","year":"2012","unstructured":"Uzun H, Yilmaz A, Kemik A, Zorba OU, Kalkan M. Association of insulin resistance with overactive bladder in female patients. Int Neurourol J. 2012;16(4):181\u20136.","journal-title":"Int Neurourol J"},{"issue":"3","key":"2170_CR41","doi-asserted-by":"publisher","first-page":"100088","DOI":"10.1016\/j.engmed.2025.100088","volume":"2","author":"X Zhao","year":"2025","unstructured":"Zhao X, Li R, Sun R, Pan Q, Lu H, Chai J. Targeting the gut microbiota-bile acid axis: Therapeutic strategies for cholestatic liver disease and metabolic dysfunction-associated steatotic liver disease. EngMedicine. 2025;2(3):100088.","journal-title":"EngMedicine"},{"key":"2170_CR42","doi-asserted-by":"crossref","unstructured":"Liu T, Ma Y, Zhang M, Wei J. Beyond Organ Boundaries: Molecular Mechanisms of Hepatic Encephalopathy and Parkinson\u2019s Disease from the Perspective of the Gut\u2013Liver\u2013Brain Axis. Research.9:1084.","DOI":"10.34133\/research.1084"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02170-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02170-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02170-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:18:21Z","timestamp":1785521901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02170-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2170"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02170-w","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"1 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the NHANES Institutional Review Board, and was performed in accordance with the Declaration of Helsinki, with all NHANES participants providing signed informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"183"}}